ClinicalTrials.govpublic full text
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
postmenopausal osteoporosis, ba058, abaloparatide-sc, abaloparatide, activextend, osteoporosis, fracture, bone loss, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913511
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.